Triumph-1 Trial of Viveta in Pulmonary Arterial Hypertension Meets …
PR Newswire - SILVER SPRING, Md., Nov. 1 /PRNewswire-FirstCall/ — United Therapeutics Corporation (NASDAQ: UTHR) and its wholly-owned subsidiary, Lung Rx, Inc., announced today the completion of their TRIUMPH-1 Phase 3 trial of Viveta, an inhaled formulation of …
